Gnmx stock buy or sell
Dec 10, 2019 · Yesterday, a Director at Aevi Genomic Medicine (GNMX – Research Report), Sol Barer, sold shares of GNMX for $532.8K.This is Barer’s first Sell trade following 10 Buy transactions. In addition to Sol Barer, 2 other GNMX executives reported Sell trades in the last month. GNMX | Aevi Genomic Medicine Inc. SEC Filings | MarketWatch Nov 05, 2019 · Aevi Genomic Medicine Inc. all SEC filings breakout by MarketWatch. View the GNMX U.S. Securities and Exchange Commission reporting information. GNMX -- Is Its Stock Price A Worthy Investment? Learn More. Aevi Genomic Medicine engages in the research and development of products in the field of biotechnology and associated medical equipment in the United States. It develops transduced autologous restorative gene therapy, TARGT platform to provide protein and peptide therapies to treat a range of chronic diseases and conditions. Aevi Genomic Medicine, Inc. (GNMX) Stock: Here’s What’s ... Today – If you put a buy order on the stock just when the market closed in the last session, the purchase would’ve resulted in a return of 3.90% so far in today’s session. Trailing Twelve Months – Over the past twelve months, those who have purchased GNMX have seen a return on Aevi Genomic Medicine, Inc. shares in the amount of 0.
Apr 03, 2020 · Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares. Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments.
28 Feb 2019 Aevi Genomic Medicine, Inc. (GNMX) is getting quite a bit of attention today Today – If you put a buy order on the stock just when the market closed in Those who sell shares short believe that the value of the stock is going 28 Jan 2020 The institutional investor bought 642.00 shares of the stock in a transaction In the most recent purchasing and selling session, Avis Budget Group Aevi Genomic Medicine Inc. (GNMX) shares on Monday's trading session, 17 Mar 2020 A lot of investors are asking: Should they be buying stocks right now? Lots of Uncertainty. The honest answer is, no one knows what is going on 20 Mar 2020 The best stocks in the Nasdaq today are travel and hospitality companies like United, Marriott and Expedia. What other stocks are rising in the Today I made $1k in less than 30 minutes on the stock #gnmx. You can now Embed Tweet. Is Aevi Genomic Medicine, Inc. #GNMX Giving A Buy Signal? Company Name: Aevi Genomic Medicine Inc., Stock Symbol: GNMX, Industry: Biotechs, Total Posts: 272, Last Post: 2/4/2020 11:00:30 PM.
GNMX Institutional Buys and Sells | Aevi Genomic Medicine ...
Search | Nasdaq Yes! I would like to receive Nasdaq communications related to Products, Industry News and Events. You can always change your preferences or unsubscribe and your contact information is covered by OTC Markets | GNMX Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities. GNMX - Aevi Genomic Medicine, Inc GNMX buy or sell Buffett ...
Buy or sell Medgenics Inc shares.
GNMX Price Target and Analyst Ratings (Aevi Genomic Medicine) Oct 31, 2019 · Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. GNMX Stock Forecast | GNMX Stock Predictions GNMX Stock Forecast. GNMX Stock Forecast - Get a free GNMX stock predictions and find out whether you should buy or sell GNMX stock. The trend analysis tool will help you make a … Aevi Genomic Medicine, Inc. (GNMX) Stock Historical Prices ...
GNMX | Aevi Genomic Medicine Inc. SEC Filings | MarketWatch
Jan 06, 2020 · Analysts who follow Aevi Genomic Medicine Inc (GNMX) on average expect it to rise 108.33% over the next twelve months. Those same analysts give the stock an average rating of Sell. That average rating puts Aevi Genomic Medicine Inc higher than 7 of st GNMX Stock Rating and Data | Aevi Genomic Medicine ...
Aevi Genomic Medicine Stock Forecast: down to 0.000001 USD ... Aevi Genomic Medicine, Inc () Stock Market infoRecommendations: Buy or sell Aevi Genomic Medicine stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Aevi Genomic Medicine share forecasts, stock quote and buy / sell signals below.According to present data Aevi Genomic Medicine's GNMX shares and potentially its market environment have been in bearish GNMX Plunges On ASCEND Data, FLZN On Track, ALNA To Report ... Jan 03, 2019 · The URIROX-1 study is designed to enroll 124 patients for a four-week treatment period. Allena expects to report topline data from URIROX-1 in the second half of 2019. Aevi Genomic Medicine, LLC (GNMX) Stock Analysis & News ...